Viatris Appoints Matthew J. Maletta as Chief Legal Officer

Core Viewpoint - Viatris Inc. announces the appointment of Matthew J. Maletta as Chief Legal Officer, effective February 9, 2026, following the transition of Brian Roman, who has served the company for over 20 years [1][2]. Group 1: Leadership Transition - Brian Roman will remain as an advisor through April 1, 2026, to ensure a smooth transition [1]. - Matthew J. Maletta brings nearly 30 years of legal experience, having previously served as Executive Vice President and Chief Legal Officer at Endo [3]. - Maletta's past experience includes over a decade at Allergan, where he was involved in significant transactions, including the $70 billion sale of Allergan to Actavis [4]. Group 2: Company Statements - Viatris CEO Scott A. Smith expressed gratitude for Brian Roman's leadership and highlighted the strength of the internal legal and compliance teams [5]. - Maletta expressed enthusiasm about joining Viatris at a pivotal time and looks forward to contributing to the company's future [5]. - Roman reflected on his experiences and accomplishments during his tenure, emphasizing the importance of the internal legal and compliance teams [5]. Group 3: Company Overview - Viatris Inc. is a global healthcare company that aims to bridge the gap between generics and branded pharmaceuticals, providing access to high-quality medicines for approximately 1 billion patients annually [6]. - The company is headquartered in the U.S. with global centers in Pittsburgh, Shanghai, and Hyderabad, India [7].